Martek’s omega-3 added to Mexican oils
This article was originally published in The Tan Sheet
Executive Summary
Ragasa, maker of Nutrioli cooking oil, will use life'sDHA in its products, Columbia, Md.-based Martek Biosciences says March 26. The nutritional oils firm said Monterrey-based Ragasa will launch a product containing life'sDHA and feature the omega-3 formulation's logo on the label. Martek seeks to highlight the presence of life'sDHA on more packaging (1"The Tan Sheet" Oct. 20, 2008, In Brief)
You may also be interested in...
Martek Pursues Direct Consumer Access With Pending Acquisition Of Amerifit
Martek Biosciences' proposed acquisition of Amerifit Brands for $200 million would mark the omega-3 DHA ingredient supplier's first major foray into consumer marketing and would substantially expand the firm's portfolio
Martek food growth
The maker of life'sDHA is using the same strategy to expand into the foods and beverage industry that it used to penetrate 99 percent of the U.S. infant formula market. Martek Biosciences President David Abramson tells analysts at the Canaccord Adams Healthy Living Conference Oct. 15 in Boston his firm continues to seek long-term exclusive agreements to supply nutritional oils for conventional foods to market leaders such as Coca-Cola and General Mills. He says Columbia, Md.-based Martek also aims for Splenda-like brand recognition by requiring its partners to highlight life'sDHA on packaging and in ads. Abramson singles out an "exciting" partnership with Dow AgroSciences that would put Martek's oil into a DHA-rich canola oil in development. This month, Martek announced supply deals that will bring its docosahexaenoic and arachidonic fatty acid formulations into Europe and China, whose emerging middle class offers growth opportunity for Martek, Abramson says (1"The Tan Sheet" Oct. 6, 2008, In Brief)
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.